0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 41-60 of 123 Articles
Editor's Correspondence | 
Mitchell H. Katz, MD
Arch Intern Med. 2011;171(9):867-868. doi:10.1001/archinternmed.2011.167.

Editor's Correspondence | 
Jennifer Brennan Braden, MD, MPH; Mark D. Sullivan, MD, PhD
Arch Intern Med. 2011;171(6):597-598. doi:10.1001/archinternmed.2011.85.

Editor's Correspondence | 
Joshua Canning, MD; Daniel E. Brooks, MD; Richard D. Gerkin, MD
Arch Intern Med. 2010;170(20):1859. doi:10.1001/archinternmed.2010.397.

Invited Commentary | 
Bimal H. Ashar, MD, MBA
Arch Intern Med. 2010;170(3):261-263. doi:10.1001/archinternmed.2009.480.

Original Investigation |  FREE
Jennifer K. MacFarquhar, RN, MPH; Danielle L. Broussard, PhD, MPH; Paul Melstrom, PhD; et al.
Arch Intern Med. 2010;170(3):256-261. doi:10.1001/archinternmed.2009.495.

Original Investigation |  FREE
Luigia Elzi, MD, MSc; Catia Marzolini, PhD; Hansjakob Furrer, MD; et al.
Arch Intern Med. 2010;170(1):57-65. doi:10.1001/archinternmed.2009.432.

Original Investigation |  FREE
Jeffrey J. Fadrowski, MD, MHS; Ana Navas-Acien, MD, PhD; Maria Tellez-Plaza, MD, MPH; et al.
Arch Intern Med. 2010;170(1):75-82. doi:10.1001/archinternmed.2009.417.

Invited Commentary | 
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS
Arch Intern Med. 2009;169(21):1985-1987. doi:10.1001/archinternmed.2009.399.

Editorial | 
John P. A. Ioannidis, MD
Arch Intern Med. 2009;169(19):1737-1739. doi:10.1001/archinternmed.2009.313.

Original Investigation |  FREE
Isabelle Pitrou, MD, MSc; Isabelle Boutron, MD, PhD; Nizar Ahmad, MD, MSc; et al.
Arch Intern Med. 2009;169(19):1756-1761. doi:10.1001/archinternmed.2009.306.

Editor's Correspondence | 
Stephen N. Rosenberg, MD, MPH; Maureen Sullivan, PharmD; Iver A. Juster, MD; et al.
Arch Intern Med. 2009;169(14):1336-1340. doi:10.1001/archinternmed.2009.224.

Editor's Correspondence | 
Arch Intern Med. 2008;168(17):1926-1933. doi:10.1001/archinte.168.17.1930-c.

Editor's Correspondence | 
Arch Intern Med. 2008;168(17):1926-1933. doi:10.1001/archinte.168.17.1931.

Editor's Correspondence | 
James R. Johnson, MD
Arch Intern Med. 2007;167(11):1207. doi:10.1001/archinte.167.11.1207-a.

Original Investigation |  FREE
Charles L. Bennett, MD, PhD, MPP; Jonathan R. Nebeker, MD, MS; Paul R. Yarnold, PhD; et al.
Arch Intern Med. 2007;167(10):1041-1049. doi:10.1001/archinte.167.10.1041.

Original Investigation |  FREE
Levita K. Hidayat, PharmD; Donald I. Hsu, PharmD; Ryan Quist, PhD; et al.
Arch Intern Med. 2006;166(19):2138-2144. doi:10.1001/archinte.166.19.2138.

Original Investigation |  FREE
Kathleen R. Page, MD; Frangiscos Sifakis, PhD; Ruben Montes de Oca, PhD; et al.
Arch Intern Med. 2006;166(17):1863-1870. doi:10.1001/archinte.166.17.1863.

Editor's Correspondence | 
Arch Intern Med. 2006;166(15):1668-1669. doi:10.1001/archinte.166.15.1668-b.

Editor's Correspondence | 
Arch Intern Med. 2006;166(15):1671-1672. doi:10.1001/archinte.166.15.1671-b.

Editorial | 
Janardan Khandekar, MD; Melin Khandekar, MD, PhD
Arch Intern Med. 2006;166(14):1440-1441. doi:10.1001/archinte.166.14.1440.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered A Post hoc Analysis of the Mainsail Study
Ellen S. de Morrée, MSc; Nicholas J. Vogelzang, MD; Daniel P. Petrylak, MD; et al.
JAMA Cardiology
Review  | 
Oncocardiology—Past, Present, and Future A Review
Edward T. H. Yeh, MD; Hui-Ming Chang, MD, MPH
JAMA Oncology
Viewpoint  | 
Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health
Lowell E. Schnipper, MD; Gregory A. Abel, MD, MPH
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.